Europe Vascular Access Devices Market

Europe Vascular Access Devices Market Size

As per the research report, the size of the Europe Vascular Access Devices Market is estimated to grow USD 1.75 billion by 2028 from USD 1.24 billion in 2023, showcasing a CAGR of 7.14% CAGR from 2023 to 2028.

The major factors that are boosting the growth of Europe vascular access devices market are increasing incidence of chronic diseases change in lifestyles of people, increasing geriatric population, high demand for these devices among people affected with chronic conditions, and the emergence of novel and innovative therapeutic methods due to technological developments. The rise in the number of chemotherapy treatments and applications of vascular access devices among paediatric patients are also boosting the growth of vascular access devices market in Europe.

Additionally, growing incidences of chronic diseases among many individuals, continuously increasing demand for active vascular access devices, the increasing prevalence of geriatric population and the emergence of technically vascular advanced devices is foreseen to provide lucrative growth to the Europe vascular access devices market. 

The factors that are resisting the growth of Europe vascular access devices market are risk of reduction of blood flow and thrombosis associated with vascular access devices, and stringent guidelines of FDA approval process to control vascular infections.

This research report segmented and sub-segmented into the following categories:

• By Type: Peripheral, Central and Accessories
• By Application: Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics Testing
• By End Users: Hospitals, Clinics And Ambulatory Care Centers and Other End Users
• By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

The European market is expected to account for the second-largest share of the market. Market growth in this region is primarily driven by factors such as the high prevalence of cardiovascular diseases; the increasing number of research studies and clinical trials for vascular access devices and the increase in chemotherapy procedures. 

The UK vascular access devices market is dominating Europe and is anticipated to contribute the most substantial share of revenues to the market during the forecast period. The factors that are contributing to the growth are technological advancements, better healthcare infrastructure, rise in demand for vascular access devices, and rise in R&D investments for these devices in the regional market. 

Key players operating in the Europe Vascular Access Devices Market profiled in this report are Becton Dickinson and Company, C.R. Bard Inc., Smiths Medical, Inc., Teleflex Incorporated, B Braun Melsungen Ag, AngioDynamics, Terumo Corporation, Nipro Medical Corporation, Edwards Lifesciences Corporation, Ameco Medical, Romsons Scientific & Surgical Pvt. Ltd, and Prodimed.